Cargando…

Malignancies in patients with cystic fibrosis: a case series

BACKGROUND: Previous reports have shown an increased number of colorectal cancers in patients with cystic fibrosis. We assessed the database of our cystic fibrosis center to identify patients with all kinds of cancer retrospectively. All patients visiting the Cystic Fibrosis Centre Innsbruck between...

Descripción completa

Detalles Bibliográficos
Autores principales: Appelt, Dorothea, Fuchs, Teresa, Steinkamp, Gratiana, Ellemunter, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767710/
https://www.ncbi.nlm.nih.gov/pubmed/35042562
http://dx.doi.org/10.1186/s13256-021-03234-1
_version_ 1784634790386860032
author Appelt, Dorothea
Fuchs, Teresa
Steinkamp, Gratiana
Ellemunter, Helmut
author_facet Appelt, Dorothea
Fuchs, Teresa
Steinkamp, Gratiana
Ellemunter, Helmut
author_sort Appelt, Dorothea
collection PubMed
description BACKGROUND: Previous reports have shown an increased number of colorectal cancers in patients with cystic fibrosis. We assessed the database of our cystic fibrosis center to identify patients with all kinds of cancer retrospectively. All patients visiting the Cystic Fibrosis Centre Innsbruck between 1995 and 2019 were included. CASE PRESENTATION: Among 229 patients with cystic fibrosis treated at the Cystic Fibrosis Centre in Innsbruck between 1995 and 2019, 11 subjects were diagnosed with a malignant disease. The median age at diagnosis was 25.2 years (mean 24.3 years). There were four gynecological malignancies (cervical intraepithelial neoplasia and cervical cancer), two hematological malignancies (acute lymphocytic leukemia), one gastrointestinal malignancy (peritoneal mesothelioma), and four malignancies from other origins (malignant melanoma, neuroblastoma, adrenocortical carcinoma, and thyroid cancer). One malignancy occurred after lung transplantation. There was a strong preponderance of females, with 10 of the 11 cases occurring in women. Six deaths were attributed to cancer. CONCLUSIONS: Most diagnoses were made below 30 years of age, and half of the subjects died from the malignant disease. Awareness of a possible malignancy is needed in patients with atypical symptoms. Regular screenings for cancer should also be considered, not only for gastrointestinal tumors.
format Online
Article
Text
id pubmed-8767710
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87677102022-01-19 Malignancies in patients with cystic fibrosis: a case series Appelt, Dorothea Fuchs, Teresa Steinkamp, Gratiana Ellemunter, Helmut J Med Case Rep Case Report BACKGROUND: Previous reports have shown an increased number of colorectal cancers in patients with cystic fibrosis. We assessed the database of our cystic fibrosis center to identify patients with all kinds of cancer retrospectively. All patients visiting the Cystic Fibrosis Centre Innsbruck between 1995 and 2019 were included. CASE PRESENTATION: Among 229 patients with cystic fibrosis treated at the Cystic Fibrosis Centre in Innsbruck between 1995 and 2019, 11 subjects were diagnosed with a malignant disease. The median age at diagnosis was 25.2 years (mean 24.3 years). There were four gynecological malignancies (cervical intraepithelial neoplasia and cervical cancer), two hematological malignancies (acute lymphocytic leukemia), one gastrointestinal malignancy (peritoneal mesothelioma), and four malignancies from other origins (malignant melanoma, neuroblastoma, adrenocortical carcinoma, and thyroid cancer). One malignancy occurred after lung transplantation. There was a strong preponderance of females, with 10 of the 11 cases occurring in women. Six deaths were attributed to cancer. CONCLUSIONS: Most diagnoses were made below 30 years of age, and half of the subjects died from the malignant disease. Awareness of a possible malignancy is needed in patients with atypical symptoms. Regular screenings for cancer should also be considered, not only for gastrointestinal tumors. BioMed Central 2022-01-19 /pmc/articles/PMC8767710/ /pubmed/35042562 http://dx.doi.org/10.1186/s13256-021-03234-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Appelt, Dorothea
Fuchs, Teresa
Steinkamp, Gratiana
Ellemunter, Helmut
Malignancies in patients with cystic fibrosis: a case series
title Malignancies in patients with cystic fibrosis: a case series
title_full Malignancies in patients with cystic fibrosis: a case series
title_fullStr Malignancies in patients with cystic fibrosis: a case series
title_full_unstemmed Malignancies in patients with cystic fibrosis: a case series
title_short Malignancies in patients with cystic fibrosis: a case series
title_sort malignancies in patients with cystic fibrosis: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767710/
https://www.ncbi.nlm.nih.gov/pubmed/35042562
http://dx.doi.org/10.1186/s13256-021-03234-1
work_keys_str_mv AT appeltdorothea malignanciesinpatientswithcysticfibrosisacaseseries
AT fuchsteresa malignanciesinpatientswithcysticfibrosisacaseseries
AT steinkampgratiana malignanciesinpatientswithcysticfibrosisacaseseries
AT ellemunterhelmut malignanciesinpatientswithcysticfibrosisacaseseries